Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. September 2025 11:00 ET | Quelle: Innovate GBM

Innovate GBM’s 2025 Investment Playbook Year to Date Review: Building a New Market for Brain Cancer Investments and Breakthroughs

Innovate GBM’s 2025 Impact Report highlights $170M in funding commitments, uniting the Community to grow an Ecosystem of innovation and progress.
24. Juni 2025 09:03 ET | Quelle: Innovate GBM

Innovate GBM Rings the NASDAQ Closing Bell in Honor of Brain Tumor Patients and Community

Innovate GBM rings the NASDAQ closing bell to honor glioblastoma patients and to spotlight the urgent need for brain tumor investment and innovation.
28. März 2024 08:00 ET | Quelle: Larkspur Biosciences, Inc.

Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024

Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024
06. März 2019 11:00 ET | Quelle: bioAffinity Technologies, Inc.

bioAffinity Technologies Selected as Finalist for Cancer Innovation Award

SAN ANTONIO, March 06, 2019 (GLOBE NEWSWIRE) -- Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company developing diagnostics and therapeutics...